l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function

Abercrombie, 1946, Estimation of nuclear population from microtome sections, Anat. Rec., 94, 239, 10.1002/ar.1090940210

Andersson, 1999, Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease, Neurobiol. Dis., 6, 461, 10.1006/nbdi.1999.0259

Andersson, 2001, cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum, J. Neurosci., 21, 9930, 10.1523/JNEUROSCI.21-24-09930.2001

Barneoud, 2000, Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system, Eur. J. Neurosci., 12, 322, 10.1046/j.1460-9568.2000.00896.x

Barneoud, 1995, Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat, Neuroscience, 67, 837, 10.1016/0306-4522(95)00112-V

Calon, 2000, Dopamine-receptor stimulation: Biobehavioral and biochemical consequences, Trends Neurosci., 23, S92, 10.1016/S1471-1931(00)00026-4

Cenci, 1992, Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum, Neuroscience, 46, 943, 10.1016/0306-4522(92)90196-9

Cenci, 1993, Neuropeptide messenger RNA expression in the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin, and prodynorphin messenger RNA levels, Neuroscience, 57, 275, 10.1016/0306-4522(93)90062-K

Cenci, 1998, l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA, Eur. J. Neurosci., 10, 2694, 10.1046/j.1460-9568.1998.00285.x

Chang, 1999, Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions, Neuroscience, 88, 617, 10.1016/S0306-4522(98)00217-6

Chase, 1998, Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine, Neurology, 50, S17, 10.1212/WNL.50.5_Suppl_5.S17

Civelli, 1985, Sequence and expression of the rat prodynorphin gene, Proc. Natl. Acad. Sci. USA, 82, 4291, 10.1073/pnas.82.12.4291

Connor, 2001, Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration, Exp. Neurol., 169, 83, 10.1006/exnr.2001.7638

Costantini, 2001, Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease, Eur. J. Neurosci., 13, 1085, 10.1046/j.0953-816x.2001.01473.x

Dickson, 1994, Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study, Neuroscience, 61, 81, 10.1016/0306-4522(94)90062-0

Fahn, 2000, The spectrum of levodopa-induced dyskinesias, Ann. Neurol., 47, S2

Flaherty, 1994, Anatomy of the basal ganglia

Howells, 1984, Molecular cloning and sequence determination of rat preproenkephalin cDNA: Sensitive probe for studying transcriptional changes in rat tissues, Proc. Natl. Acad. Sci. USA, 81, 7651, 10.1073/pnas.81.23.7651

Karlsson, 1999, Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones, Brain Res., 821, 546, 10.1016/S0006-8993(99)01176-2

Kirik, 1998, Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat, Exp. Neurol., 152, 259, 10.1006/exnr.1998.6848

Kirik, 2000, Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system, J. Neurosci., 20, 4686, 10.1523/JNEUROSCI.20-12-04686.2000

Kirik, 2001, Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration, J. Neurosci., 21, 2889, 10.1523/JNEUROSCI.21-08-02889.2001

Kish, 1988, Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications, N. Engl. J. Med., 318, 876, 10.1056/NEJM198804073181402

Lee, 2000, Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease, Brain, 123, 1365, 10.1093/brain/123.7.1365

Lee, 1996, Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat, Neuroscience, 72, 641, 10.1016/0306-4522(95)00571-4

Lundblad, 2002, Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease, Eur. J. Neurosci., 15, 120, 10.1046/j.0953-816x.2001.01843.x

Montoya, 1991, The “staircase test”: A measure of independent forelimb reaching and grasping abilities in rats, J. Neurosci. Methods., 36, 219, 10.1016/0165-0270(91)90048-5

Mouradian, 1989, Pathogenesis of dyskinesias in Parkinson's disease, Ann. Neurol., 25, 523, 10.1002/ana.410250521

Nikkhah, 2000, Microtransplantation of nigral dopamine neurons: A step-by-step recipe, 207, 10.1007/978-1-59259-690-4_12

Nutt, 1990, Levodopa-induced dyskinesia: Review, observations and speculations, Neurology, 40, 340, 10.1212/WNL.40.2.340

Obeso, 2000, Levodopa motor complications in Parkinson's disease, Trends Neurosci., 23, S2, 10.1016/S1471-1931(00)00031-8

Olsson, 1995, Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test, J. Neurosci., 15, 3863, 10.1523/JNEUROSCI.15-05-03863.1995

Paxinos, 1997

Pisa, 1988, Motor functions of the striatum in the rat: critical role of the lateral region in tongue and forelimb reaching, Neuroscience, 24, 453, 10.1016/0306-4522(88)90341-7

Salamone, 1993, Ventrolateral striatal dopamine depletions impair feeding and food handling in rats, Pharmacol. Biochem. Behav., 44, 605, 10.1016/0091-3057(93)90174-R

Sauer, 1994, Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat, Neuroscience, 59, 401, 10.1016/0306-4522(94)90605-X

Schallert, 2000, Intervention strategies for degeneration of dopamine neurons in parkinsonism: Optimizing behavioral assessment of outcome, 131

Strömberg, 1992, Electrophysiological and in vitro electrochemical recordings in rats with intraventricular human xenografts, 303

West, 1999, Stereological methods for estimating the total number of neurons and synapses: Issues of precision and bias, Trends Neurosci., 22, 51, 10.1016/S0166-2236(98)01362-9

Westin, 2001, Persistent changes in striatal gene expression induced by long-term l-DOPA treatment in a rat model of Parkinson's disease, Eur. J. Neurosci., 14, 1171, 10.1046/j.0953-816x.2001.01743.x

Winkler, 1999, Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants, Exp. Neurol., 155, 165, 10.1006/exnr.1998.6916

Winkler, 2000, Transplantation in the rat model of Parkinson's disease: Ectopic versus homotopic graft placement, Prog. Brain Res., 127, 233, 10.1016/S0079-6123(00)27012-X

Winkler, 1996, Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease, J. Neurosci., 16, 7206, 10.1523/JNEUROSCI.16-22-07206.1996

Zigmond, 1990, Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications, Trends Neurosci., 13, 290, 10.1016/0166-2236(90)90112-N